169 related articles for article (PubMed ID: 16730340)
1. Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram.
Dlaboga D; Hajjhussein H; O'Donnell JM
Brain Res; 2006 Jun; 1096(1):104-12. PubMed ID: 16730340
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme.
Zhang HT; Huang Y; Jin SL; Frith SA; Suvarna N; Conti M; O'Donnell JM
Neuropsychopharmacology; 2002 Oct; 27(4):587-95. PubMed ID: 12377395
[TBL] [Abstract][Full Text] [Related]
3. Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms.
Takahashi M; Terwilliger R; Lane C; Mezes PS; Conti M; Duman RS
J Neurosci; 1999 Jan; 19(2):610-8. PubMed ID: 9880581
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain.
Iona S; Cuomo M; Bushnik T; Naro F; Sette C; Hess M; Shelton ER; Conti M
Mol Pharmacol; 1998 Jan; 53(1):23-32. PubMed ID: 9443929
[TBL] [Abstract][Full Text] [Related]
5. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family.
McPhee I; Pooley L; Lobban M; Bolger G; Houslay MD
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):965-74. PubMed ID: 7575434
[TBL] [Abstract][Full Text] [Related]
6. Noradrenergic activity differentially regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4) in rat brain.
Ye Y; Conti M; Houslay MD; Farooqui SM; Chen M; O'Donnell JM
J Neurochem; 1997 Dec; 69(6):2397-404. PubMed ID: 9375671
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function.
Zhao Y; Zhang HT; O'Donnell JM
J Pharmacol Exp Ther; 2003 Oct; 307(1):246-53. PubMed ID: 12954819
[TBL] [Abstract][Full Text] [Related]
8. Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration.
D'Sa C; Eisch AJ; Bolger GB; Duman RS
Eur J Neurosci; 2005 Sep; 22(6):1463-75. PubMed ID: 16190900
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
10. Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A) in rat brain.
Ye Y; Jackson K; O'Donnell JM
J Neurochem; 2000 Mar; 74(3):1257-62. PubMed ID: 10693959
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study.
Miró X; Pérez-Torres S; Artigas F; Puigdomènech P; Palacios JM; Mengod G
Neuropharmacology; 2002 Dec; 43(7):1148-57. PubMed ID: 12504921
[TBL] [Abstract][Full Text] [Related]
12. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
Erdogan S; Houslay MD
Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
[TBL] [Abstract][Full Text] [Related]
13. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages.
Jin SL; Lan L; Zoudilova M; Conti M
J Immunol; 2005 Aug; 175(3):1523-31. PubMed ID: 16034090
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
[TBL] [Abstract][Full Text] [Related]
15. Noradrenergic lesions differentially alter the expression of two subtypes of low Km cAMP-sensitive phosphodiesterase type 4 (PDE4A and PDE4B) in rat brain.
Farooqui SM; Zhang K; Makhay M; Jackson K; Farooqui SQ; Cherry JA; O'Donnell JM
Brain Res; 2000 Jun; 867(1-2):52-61. PubMed ID: 10837797
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain.
Pérez-Torres S; Miró X; Palacios JM; Cortés R; Puigdoménech P; Mengod G
J Chem Neuroanat; 2000 Dec; 20(3-4):349-74. PubMed ID: 11207431
[TBL] [Abstract][Full Text] [Related]
17. Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors.
Saldou N; Obernolte R; Huber A; Baecker PA; Wilhelm R; Alvarez R; Li B; Xia L; Callan O; Su C; Jarnagin K; Shelton ER
Cell Signal; 1998 Jun; 10(6):427-40. PubMed ID: 9720765
[TBL] [Abstract][Full Text] [Related]
18. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B.
Manning CD; McLaughlin MM; Livi GP; Cieslinski LB; Torphy TJ; Barnette MS
J Pharmacol Exp Ther; 1996 Feb; 276(2):810-8. PubMed ID: 8632354
[TBL] [Abstract][Full Text] [Related]
19. Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats.
Zhang HT; Huang Y; Mishler K; Roerig SC; O'Donnell JM
Psychopharmacology (Berl); 2005 Oct; 182(1):104-15. PubMed ID: 16010541
[TBL] [Abstract][Full Text] [Related]
20. Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists.
Torphy TJ; Zhou HL; Foley JJ; Sarau HM; Manning CD; Barnette MS
J Biol Chem; 1995 Oct; 270(40):23598-604. PubMed ID: 7559525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
